Advertisement
AxoGen, Inc.

AxoGen, Inc. (AXGN) Stock Overview

Explore AxoGen, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

AXGNโ—NASDAQ
HealthcareMedical - Devices
$42.15
$0.69(1.66%)
U.S. Market is Open ยท 15:00
Advertisement

AxoGen, Inc. (AXGN)

Meyka AI Score

Z

Key Financials

Market Cap2.3B
P/E Ratio-67.81
EPS (TTM)$-0.64
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

AXGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AxoGen, Inc. (AXGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -67.81 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.57%
5-Day Change
-2.36%
1-Month Change
-1.71%
3-Month Change
34.70%
6-Month Change
37.75%
Year-to-Date (YTD) Change
26.31%
1-Year Change
287.08%
3-Year Change
352.30%
5-Year Change
109.95%
All-Time (Max) Change
933.50%

Contact Information

386 462 6800
13631 Progress Boulevard, Alachua, FL, 32615

Company Facts

4,510 Employees
IPO DateDec 17, 1986
CountryUS
Actively Trading

Frequently Asked Questions